Merkoša sitáhtat
APA-čujuhus (7. p.)
Pleguezuelos, P., Sibila, M., Cuadrado-Matías, R., López-Jiménez, R., Pérez, D., Huerta, E., . . . Balasch, M. (2022). Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and <i>Mycoplasma hyopneumoniae</i> When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection. MDPI AG.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Pleguezuelos, Patricia, et al. Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and <i>Mycoplasma Hyopneumoniae</i> When Administered at 3 Days of Age and 3 Weeks Later Against Porcine Circovirus 2 (PCV-2) Infection. MDPI AG, 2022.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Pleguezuelos, Patricia, et al. Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and <i>Mycoplasma Hyopneumoniae</i> When Administered at 3 Days of Age and 3 Weeks Later Against Porcine Circovirus 2 (PCV-2) Infection. MDPI AG, 2022.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.